🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Hadi Bagheri

Hadi Bagheri

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.22486571

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Papers

Driven by 12 papers — median percentile 0. Top paper: “Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy”.

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3726

N/A

1.1DataRank · unranked

24 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo Lara, Sumanta K. Pal +30 more

Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study

BMJ Open Diabetes Research & Care(2021)10.1136/bmjdrc-2021-002447

N/A

0.831DataRank · unranked

28 citations

Annemarie Wentzel, ELYSSA M. SHOUP, NANA H. OSEI-TUTU, Thomas Hormenu, Arielle C. Patterson +7 more

Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (ACDC)

Vascular Medicine(2024)10.1177/1358863x241235669

N/A

0.525DataRank · unranked

13 citations

Cornelia Cudrici, Mahmood Rashidi, Yi‐Ping Fu, Rebecca D. Huffstutler, Katherine Carney +10 more

A Combined Region- and Pixel-Based Deep Learning Approach for Quantifying Abdominal Adipose Tissue in Adolescents Using Dixon Magnetic Resonance Imaging

Tomography(2023)10.3390/tomography9010012

N/A

0.317DataRank · unranked

5 citations

Harish RaviPrakash, Ashlee M. Simmons, Rhasaan T.M. Bovell, Pedro E. Martinez, Jack A. Yanovski +7 more

Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy

Frontiers in Oncology(2021)10.3389/fonc.2021.789078

N/A

0DataRank · unranked

28 citations

Brittni N. Moore, Hadi Bagheri, Seth M. Steinberg, Jon R. Inglefield, Kim Dunham +16 more

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.22486571

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Supplementary Figure from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Figshare(2023)10.1158/1078-0432.22486556.v1

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Data from Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

(2023)10.1158/1078-0432.c.6532346.v1

Top 100%

0DataRank

Top 100%0 citations

Scot A. Niglio, Amir Mortazavi, Rosa Nadal, Primo N. Lara, Sumanta K. Pal +30 more

Comparison of CT and Dixon MR Abdominal Adipose Tissue Quantification Using a Unified Computer-Assisted Software Framework

Tomography(2023)10.3390/tomography9030085

N/A

0DataRank · unranked

12 citations

Zara Ali, Hadi Bagheri, Fahimul Huda, Bernadette Redd, Elizabeth C. Jones +1 more

Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma

Current Oncology(2021)10.3390/curroncol28060370

N/A

0DataRank · unranked

5 citations

Ahmad Shafiei, David Venzon, David J. Liewehr, Michal Mauda Havanuk, Maran Ilanchezhian +11 more

Vertebral Bone Mineral Density, Vertebral Strength, and Syndesmophyte Growth in Ankylosing Spondylitis: The Importance of Bridging

Arthritis & Rheumatology(2022)10.1002/art.42120

N/A

0DataRank · unranked

13 citations

Hadi Bagheri, David C. Lee, Ahmad Shafiei, Tony M. Keaveny, Lawrence Yao +2 more

Splenic Size and Volume Measurements in Patients with Chronic Lymphocytic Leukemia

Academic Radiology(2022)10.1016/j.acra.2022.06.013

N/A

0DataRank · unranked

6 citations

Li‐Yueh Hsu, Clare Sun, Pia Nierman, Adrian Wiestner, Elizabeth C. Jones +2 more